Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | SLNO | CNTA | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Soleno Therapeutics Inc | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.36 | 56.00 | 15.21 | ||
| High | 6.58 | 56.50 | 15.69 | ||
| Low | 6.34 | 55.30 | 14.87 | ||
| Last | 6.40 | 55.86 | 15.67 | ||
| Change | +0.08 | +0.80 | +0.63 | ||
| % Change | +1.27% | +1.45% | +4.19% | ||
| Volume | 3,630,400 | 362,400 | 316,500 | ||
| 20-Day Average Volume | 3,967,730 | 812,845 | 280,840 | ||
| Previous Close | 6.32 | 55.06 | 15.04 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.55 | 53.63 | 15.69 | ||
| 20-Day Raw Stochastic | 39.13% | 85.58% | 51.63% | ||
| 20-Day Relative Strength | 46.86% | 59.07% | 53.31% | ||
| Weighted Alpha | -25.89 | +112.43 | +113.72 | ||
| Today's Opinion | 96% Sell | 100% Buy | 80% Buy | ||
| Previous Opinion | 96% Sell | 100% Buy | 64% Buy | ||
| Last Month's Opinion | 100% Sell | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.23% since 10/25/24 | +1.71% since 10/25/24 | +1.10% since 10/25/24 | ||
| Low | 6.32 on 10/31/24 | 54.10 on 10/31/24 | 14.48 on 10/31/24 | ||
| High | 6.95 on 10/28/24 | 57.28 on 10/28/24 | 15.86 on 10/28/24 | ||
| 1-Month | |||||
| %Chg | +3.73% since 10/01/24 | +12.55% since 10/01/24 | -8.90% since 10/01/24 | ||
| Low | 5.95 on 10/10/24 | 47.43 on 10/07/24 | 14.48 on 10/31/24 | ||
| High | 7.10 on 10/17/24 | 57.28 on 10/28/24 | 17.16 on 10/02/24 | ||
| 3-Month | |||||
| %Chg | -12.81% since 08/01/24 | +13.54% since 08/01/24 | +52.28% since 08/01/24 | ||
| Low | 5.89 on 09/04/24 | 42.69 on 08/08/24 | 9.10 on 08/05/24 | ||
| High | 8.16 on 08/26/24 | 57.28 on 10/28/24 | 17.59 on 09/13/24 | ||
| 6-Month | |||||
| %Chg | -23.26% since 05/01/24 | +17.50% since 05/01/24 | +65.30% since 05/01/24 | ||
| Low | 5.89 on 09/04/24 | 36.93 on 06/26/24 | 7.75 on 05/29/24 | ||
| High | 10.66 on 05/15/24 | 57.28 on 10/28/24 | 17.59 on 09/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,799,098 | 2,171,390 | 1,775,631 | ||
| Shares Outstanding, K | 281,109 | 38,872 | 113,314 | ||
| Annual Sales | 44,580,000 | 0 | 6,850,000 | ||
| Annual Net Income | -328,070,000 | -38,990,000 | -151,090,000 | ||
| Last Quarter Sales | 14,420,000 | 0 | 0 | ||
| Last Quarter Net Income | -97,540,000 | -21,850,000 | -38,050,000 | ||
| 60-Month Beta | 0.81 | -1.44 | 1.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 08/08/24 | -0.57 on 08/07/24 | -0.40 on 08/13/24 | ||
| Latest Earnings Date | 11/06/24 | 11/05/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||